SDH mutations establish a hypermethylator phenotype in paraganglioma

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications

Krueger, F., & Andrews, S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr167 · Cited by 5,161 · see citing works

The Epigenomics of Cancer

Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515 · see citing works

Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · see citing works

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works

CpG island methylator phenotype in colorectal cancer

Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,506 · see citing works

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,430 · see citing works

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337 · see citing works

Linking DNA methylation and histone modification: patterns and paradigms

Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · see citing works

Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data

Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116 · see citing works

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase

Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 2× · see citing works

Mutations in <i>SDHD</i> , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma

Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · see citing works

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635 · see citing works

The power and the promise of DNA methylation markers

Laird, P. W. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1045 · Cited by 1,548 · see citing works

Phaeochromocytoma

Lenders, J. W. M., Eisenhofer, G., Mannelli, M., & Pacák, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,541 · see citing works

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

Takai, D., & Jones, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052410099 · Cited by 1,507 · see citing works

Germ-Line Mutations in Nonsyndromic Pheochromocytoma

Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,350 · see citing works

Cancer epigenetics reaches mainstream oncology

Rodríguez‐Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,207 · see citing works

Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis

Meissner, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki901 · Cited by 1,203 · see citing works

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors

Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012) · Genes &amp; Development · doi:10.1101/gad.191056.112 · Cited by 1,188 · cited 2× · see citing works

Epigenetic stem cell signature in cancer

Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143 · see citing works

Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations

Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865 · see citing works

Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling

Gu, H., Smith, Z. D., Bock, C., Boyle, P., Gnirke, A., & Meissner, A. (2011) · Nature Protocols · doi:10.1038/nprot.2010.190 · Cited by 750 · see citing works

Genetic Testing in Pheochromocytoma or Functional Paraganglioma

Amar, L., Bertherat, J. Y., Baudin, É., Ajzenberg, C., Paillerets, B. B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 683 · see citing works

Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells

Tsai, H.-C., Li, H., Neste, L. V., Cai, Y., Robert, C., Rassool, F. V., Shin, J., Harbom, K., Beaty, R. M., Pappou, E. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 651 · see citing works

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking <i>KIT</i> and <i>PDGFRA</i> mutations

Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628 · see citing works

Genome-scale analysis of aberrant DNA methylation in colorectal cancerPreprint

Hinoue, T., Weisenberger, D. J., Lange, C., Shen, H., Byun, H., Van, D., Malik, S., Pan, F., Noushmehr, H., van, C., et al. (2011) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 604 · see citing works

Genome-Wide Dna Methylation Profiling Using Infinium ® Assay

Bibikova, M. V., Le, J. M., Barnes, B., Saedinia-Melnyk, S., Zhou, L., Shen, R., & Gunderson, K. L. (2009) · Epigenomics · doi:10.2217/epi.09.14 · Cited by 592 · see citing works

Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.

Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaı̂tre, X. (2003) · PubMed · Cited by 541 · see citing works

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F. B. M., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 534 · see citing works

Succinate dehydrogenase – Assembly, regulation and role in human disease

Rutter, J. P., Winge, D. R., & Schiffman, J. D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.03.001 · Cited by 459 · see citing works

Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas

Amar, L., Baudin, É., Burnichon, N., Peyrard, S., Silvera, S., Bertherat, J. Y., BERTAGNA, X. Y., Schlumberger, M. J., Jeunemaı̂tre, X., Gimenez‐Roqueplo, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0709 · Cited by 447 · see citing works

A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas

Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443 · see citing works

Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis

Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., & Tavazoie, S. F. (2012) · Cell · doi:10.1016/j.cell.2012.10.028 · Cited by 415 · see citing works

The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway

Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364 · see citing works

Germline SDHB Mutations and Familial Renal Cell Carcinoma

Ricketts, C. J., Woodward, E. R., Killick, P., Morris, M. R., Astuti, D., Latif, F., & Maher, E. R. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn254 · Cited by 341 · see citing works

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

Burnichon, N., Cascón, A., Schiavi, F., Morales, N. P., Comino‐Méndez, I., Abermil, N., Inglada‐Pérez, L., de Cubas, A. A., Amar, L., Barontini, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0160 · Cited by 331 · see citing works

Genetic Profiling of Epithelial Cells Expressing E-Cadherin Repressors Reveals a Distinct Role for Snail, Slug, and E47 Factors in Epithelial-Mesenchymal Transition

Moreno‐Bueno, G., Cubillo, E., Sarrió, D., Peinado, H., Rodríguez-Pinilla, S. M., Villa, S., Bolós, V., Jordà, M., Fabra, À., Portillo, F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0479 · Cited by 320 · see citing works

Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes

Eisenhofer, G., Walther, M. M., Huynh, T., Li, S., Bornstein, S. R., Vortmeyer, A. O., Mannelli, M., Goldstein, D. S., Linehan, W. M., Lenders, J. W. M., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7496 · Cited by 313 · see citing works

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma

Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reyniès, A., Vénisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J. Y., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 304 · see citing works

An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes

Gimenez‐Roqueplo, A., Dahia, P. L. M., & Robledo, M. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1301302 · Cited by 289 · see citing works

SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes

Pasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 268 · see citing works

The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse

Eppig, J. T., Blake, J. A., Bult, C. J., Kadin, J. A., Richardson, J. E., & the Mouse Genome Database Group (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr974 · Cited by 243 · see citing works

The Warburg effect is genetically determined in inherited pheochromocytomas

Favier, J., Brière, J.-J., Burnichon, N., Rivière, J., Vescovo, L., Benit, P., Giscos-Douriez, I., De Reyniès, A., Bertherat, J., Badoual, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007094 · Cited by 232 · see citing works

Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions

Houseman, E. A., Christensen, B. C., Yeh, R., Marsit, C. J., Karagas, M. R., Wrensch, M., Nelson, H. H., Wiemels, J. L., Zheng, S., Wiencke, J. K., et al. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-365 · Cited by 208 · see citing works

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma

Eisenhofer, G., Pacák, K., Huynh, T.-T., Qin, N., Bratslavsky, G., Linehan, W. M., Mannelli, M., Friberg, P., Grebe, S. K., Timmers, H. J. L. M., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0211 · Cited by 206 · see citing works

Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer.

Esteller, M., Guo, M., Moreno, V. R., Peinado, M. A., Capellá, G., Galm, O., Baylin, S. B., & Herman, J. G. (2002) · PubMed · Cited by 153 · see citing works

Mitochondrial succinate is instrumental for HIF1α nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions

Brière, J.-J., Favier, J., Bénit, P., Ghouzzi, V. E., Lorenzato, A., Rabier, D., Renzo, M. F. D., Gimenez‐Roqueplo, A., & Rustin, P. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi359 · Cited by 153 · see citing works

Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma

Burnichon, N., Buffet, A., Parfait, B., Letouzé, É., Laurendeau, I., Loriot, C., Pasmant, É., Abermil, N., Valeyrie‐Allanore, L., Bertherat, J. Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds374 · Cited by 147 · see citing works

Epithelial to Mesenchymal Transition Is Activated in Metastatic Pheochromocytomas and Paragangliomas Caused by SDHB Gene Mutations

Loriot, C., Burnichon, N., Gadessaud, N., Vescovo, L., Amar, L., Libé, R., Bertherat, J. Y., Plouin, P., Jeunemaı̂tre, X., Gimenez‐Roqueplo, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3437 · Cited by 120 · see citing works

Cellular Retinol-Binding Protein I, a Regulator of Breast Epithelial Retinoic Acid Receptor Activity, Cell Differentiation, and Tumorigenicity

Farias, E., Ong, D. E., Ghyselinck, N. B., Nakajo, S., Kuppumbatti, Y. S., & López, R. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji004 · Cited by 77 · see citing works

HIF2AMutations in Paraganglioma with Polycythemia

Favier, J., Buffet, A., & Gimenez‐Roqueplo, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1211953 · Cited by 65 · see citing works

Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior

Geli, J., Kiss, N. B., Karimi, M., Lee, J.-J., Bäckdahl, M., Ekström, T. J., & Larsson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1867 · Cited by 64 · see citing works

Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.

Senanayake, P. D., Denker, J., Bravo, E. L., & Graham, R. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118310 · Cited by 48 · see citing works

Genome-Wide Analysis of DNA Methylation in Low Cell Numbers by Reduced Representation Bisulfite Sequencing

Smallwood, S. A., & Kelsey, G. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-011-3_12 · Cited by 42 · see citing works

Untuning the tumor metabolic machine: HIF-α: pro- and antitumorigenic?

Young, R. M., & Simon, M. C. (2012) · Nature Medicine · doi:10.1038/nm.2865 · Cited by 31 · see citing works

Mouse Adrenal Chromaffin Cell Isolation

Kolski‐Andreaco, A., Cai, H., Currle, D. S., Chandy, K. G., & Chow, R. H.-P. (2007) · Journal of Visualized Experiments · doi:10.3791/129 · Cited by 18 · see citing works

Mouse Adrenal Chromaffin Cell Isolation

Kolski‐Andreaco, A., Cai, H., Currle, D. S., Chandy, K. G., & Chow, R. H.-P. (2007) · Journal of Visualized Experiments · doi:10.3791/129-v · Cited by 11 · see citing works

The emerging hallmarks of cancer metabolism

Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works

Mitochondrial TCA cycle metabolites control physiology and disease

Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813 · see citing works

The diverse roles of DNA methylation in mammalian development and disease

Greenberg, M., & Bourc’his, D. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0159-6 · Cited by 2,160 · see citing works

Glutamine reliance in cell metabolism

Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental &amp; Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works

Targeting Metabolism for Cancer Therapy

Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · see citing works

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

Fishbein, L. M., Leshchiner, I., Walter, V., Danilova, L., Robertson, A. G., Johnson, A. R., Lichtenberg, T. M., Murray, B. A., Ghayee, H. K., Else, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.001 · Cited by 795 · see citing works

Metabolic targets for cancer therapy

Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 705 · see citing works

Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine

Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · see citing works

The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications

Linehan, W. M., & Ricketts, C. J. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0211-5 · Cited by 629 · see citing works

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., et al. (2016) · Nature · doi:10.1038/nature19353 · Cited by 584 · see citing works

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

Capper, D., Stichel, D., Sahm, F., Jones, D., Schrimpf, D., Sill, M., Schmid, S., Hovestadt, V., Reuß, D., Koelsche, C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1879-y · Cited by 571 · see citing works

Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation

Lee, J. V., Carrer, A., Shah, S., Snyder, N. W., Wei, S., Venneti, S., Worth, A. J., Yuan, Z.-F., Lim, H.-W., Liu, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.004 · Cited by 563 · see citing works

Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.

Tretter, L., Patócs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta · doi:10.1016/j.bbabio.2016.03.012 · Cited by 502 · see citing works

Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

Favier, J., Amar, L., & Gimenez‐Roqueplo, A. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.188 · Cited by 484 · see citing works

Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity

Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545 · see citing works

Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer

Plass, C., Pfister, S. M., Lindroth, A. M., Bogatyrova, O., Claus, R., & Lichter, P. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3554 · Cited by 448 · see citing works

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Faßnacht, M., Assié, G., Baudin, É., Eisenhofer, G., de la Fouchardière, C., Haak, H. R., de Krijger, R. R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 446 · see citing works

Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death

García‐Bermúdez, J., Baudrier, L., Bayraktar, E. C., Shen, Y., La, K., Guarecuco, R., Yücel, B., Fiore, D., Tavora, B., Freinkman, E., et al. (2019) · Nature · doi:10.1038/s41586-019-0945-5 · Cited by 424 · see citing works

Personalized Management of Pheochromocytoma and Paraganglioma

Nölting, S., Bechmann, N., Taïeb, D., Beuschlein, F., Faßnacht, M., Kroiß, M., Eisenhofer, G., Grossman, A. B., & Pacák, K. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab019 · Cited by 441 · see citing works

Altered metabolite levels in cancer: implications for tumour biology and cancer therapy

Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406 · see citing works

Oncometabolites: linking altered metabolism with cancer

Yang, M. H., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 424 · see citing works

Metabolic control of epigenetics in cancer

Kinnaird, A. S., Zhao, S., Wellen, K. E., & Michelakis, E. D. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.82 · Cited by 419 · see citing works

Methionine is a metabolic dependency of tumor-initiating cells

Wang, Z., Yip, L. Y., Lee, J. H. J., Wu, Z., Chew, H. Y., Chong, P. K. W., Teo, C. C., Ang, H. Y.-K., Peh, K. L. E., Yuan, J. X., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0423-5 · Cited by 425 · see citing works

Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas

Castro‐Vega, L. J., Buffet, A., de Cubas, A. A., Cascón, A., Menara, M., Khalifa, E., Amar, L., Azriel, S., Bourdeau, I., Chabre, O., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt639 · Cited by 398 · see citing works

Mitochondria and Epigenetics – Crosstalk in Homeostasis and Stress

Matilainen, O., Quirós, P. M., & Auwerx, J. H. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.02.004 · Cited by 368 · see citing works

EMT Factors and Metabolic Pathways in Cancer

Georgakopoulos‐Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V. E., & Zaravinos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00499 · Cited by 348 · see citing works

Metabolic Regulation of Histone Post-Translational Modifications

Fan, J., Krautkramer, K. A., Feldman, J. L., & Denu, J. M. (2015) · ACS Chemical Biology · doi:10.1021/cb500846u · Cited by 334 · see citing works

Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer

Sciacovelli, M., & Frezza, C. (2017) · FEBS Journal · doi:10.1111/febs.14090 · Cited by 324 · see citing works

New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification

Crona, J., Taïeb, D., & Pacák, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 322 · see citing works

Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes

Laukka, T., Mariani, C. J., Ihantola, T., Cao, J. Z., Hokkanen, J., Kaelin, W. G., Godley, L. A., & Koivunen, P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688762 · Cited by 307 · see citing works

Dysregulated metabolism contributes to oncogenesis

Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 306 · see citing works

Role of mitochondrial dysfunction in cancer progression

Hsu, C., Tseng, L., & Lee, H. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216641787 · Cited by 306 · see citing works

Mitochondrial DNA variation and cancer

Kopinski, P. K., Singh, L. N., Zhang, S., Lott, M. T., & Wallace, D. C. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00358-w · Cited by 301 · see citing works

Mitochondrial complex ii: At the crossroads

Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295 · see citing works

Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis

Cardaci, S., Zheng, L., MacKay, G., van den Broek, N. J. F., MacKenzie, E. D., Nixon, C., Stevenson, D., Tumanov, S., Bulusu, V., Kamphorst, J. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3233 · Cited by 286 · see citing works

Metabolic control of methylation and acetylation

Su, X., Wellen, K. E., & Rabinowitz, J. D. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.10.030 · Cited by 296 · see citing works

Marked for death: Targeting epigenetic changes in cancer

Pfister, S. X., & Ashworth, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.256 · Cited by 288 · see citing works

Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

Rednam, S. P., Erez, A., Druker, H. A., Janeway, K. A., Kamihara, J., Kohlmann, W. K., Nathanson, K. L., States, L. J., Tomlinson, G. E., Villani, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0547 · Cited by 282 · see citing works

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas

The NGS in PPGL (NGSnPPGL) Study Group, Toledo, R. A., Burnichon, N., Cascón, A., Benn, D. E., Bayley, J., Welander, J., Tops, C. M. J., Firth, H. V., Dwight, T., et al. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.185 · Cited by 270 · see citing works

The functional roles of TCA cycle metabolites in cancer

Eniafe, J., & Jiang, S. (2021) · Oncogene · doi:10.1038/s41388-020-01639-8 · Cited by 274 · see citing works

Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches

Wong, C. C., Qian, Y., & Yu, J. Q. (2017) · Oncogene · doi:10.1038/onc.2016.485 · Cited by 260 · see citing works

TGF-β signaling in the tumor metabolic microenvironment and targeted therapies

Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262 · see citing works

Epithelial–mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation

Li, L., & Li, W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.004 · Cited by 254 · see citing works

Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours

Missiroli, S., Perrone, M., Genovese, I., Pinton, P., & Giorgi, C. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102943 · Cited by 258 · see citing works

Defects in mitochondrial metabolism and cancer

Gaude, E., & Frezza, C. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-10 · Cited by 249 · see citing works

TET proteins and the control of cytosine demethylation in cancer

Scourzic, L., Mouly, E., & Bernard, O. (2015) · Genome Medicine · doi:10.1186/s13073-015-0134-6 · Cited by 251 · see citing works

NADP+-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance

Li, F., He, X., Ye, D., Lin, Y., Yu, H., Yao, C., Huang, L., Zhang, J., Wang, F., Xu, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.017 · Cited by 244 · see citing works

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer

Hua, W., ten Dijke, P., Kostidis, S., Giera, M. A., & Hornsveld, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03398-6 · Cited by 237 · see citing works

Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism

Lussey-Lepoutre, C., Hollinshead, K. E. R., Ludwig, C., Menara, M., Morin, A., Castro-Vega, L.-J., Parker, S. J., Janin, M., Martinelli, C., Ottolenghi, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9784 · Cited by 227 · see citing works

Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer

Sayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231 · see citing works

2-Oxoglutarate-dependent dioxygenases in cancer

Losman, J.-A., Koivunen, P., & Kaelin, W. G. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00303-3 · Cited by 225 · see citing works

Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis

Ohshima, K., & Morii, E. (2021) · Metabolites · doi:10.3390/metabo11010028 · Cited by 230 · see citing works

IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives

de Botton, S., Mondesir, J., Willekens, C., & Touat, M. (2016) · Journal of Blood Medicine · doi:10.2147/jbm.s70716 · Cited by 220 · see citing works

Oncometabolites in renal cancer

Yong, C., Stewart, G. D., & Frezza, C. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0210-z · Cited by 212 · see citing works

Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use

Zdzisińska, B., Żurek, A., & Kandefer-Szerszeń, M. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0406-x · Cited by 221 · see citing works

Undercover: gene control by metabolites and metabolic enzymesPreprint

van der Knaap, J. A., & Verrijzer, C. P. (2016) · Genes & Development · doi:10.1101/gad.289140.116 · Cited by 213 · see citing works

Hereditary Kidney Cancer Syndromes

Haas, N. B., & Nathanson, K. L. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.10.001 · Cited by 209 · see citing works

Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly

Shenoy, N. K., Creagan, E. T., Witzig, T. E., & Levine, M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.014 · Cited by 207 · see citing works

Regulation of succinate dehydrogenase and role of succinate in cancer

Dalla Pozza, E., Dando, I., Pacchiana, R., Liboi, E., Scupoli, M. T., Donadelli, M., & Palmieri, M. (2020) · Seminars in Cell &amp; Developmental Biology · doi:10.1016/j.semcdb.2019.04.013 · Cited by 212 · see citing works

SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

Hadoux, J., Favier, J., Scoazec, J., Leboulleux, S., Ghuzlan, A. A., Caramella, C., Deandreis, D., Borget, I., Loriot, C., Chougnet, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28913 · Cited by 208 · see citing works

Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment

Martucci, V. L., & Pacák, K. (2014) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2014.01.001 · Cited by 204 · see citing works

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities

Ge, T., Gu, X., Jia, R., Ge, S., Chai, P., Zhuang, A., & Fan, X. (2022) · 癌症：英文版 · doi:10.1002/cac2.12374 · Cited by 206 · see citing works

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas

Castro‐Vega, L. J., Letouzé, É., Burnichon, N., Buffet, A., Disderot, P.-H., Khalifa, E., Loriot, C., Elarouci, N., Morin, A., Menara, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7044 · Cited by 195 · see citing works

Recurrent epimutation of SDHC in gastrointestinal stromal tumors

Killian, J. K., Miettinen, M., Walker, R. L., Wang, Y., Zhu, Y. J., Waterfall, J. J., Noyes, N., Retnakumar, P., Yang, Z., Smith, W. I., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009961 · Cited by 194 · see citing works

Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications

Wei, Q., Qian, Y., Yu, J. Q., & Wong, C. C. (2020) · Oncogene · doi:10.1038/s41388-020-01432-7 · Cited by 188 · see citing works

Metabolism and Epigenetics

Janke, R., Dodson, A. E., & Rine, J. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125544 · Cited by 192 · see citing works

Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene

Cascón, A., Comino‐Méndez, I., Currás-Freixes, M., de Cubas, A. A., Contreras, L., Richter, S., Peitzsch, M., Mančíková, V., Inglada‐Pérez, L., Pérez‐Barrios, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv053 · Cited by 193 · see citing works

Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad

Haller, F., Moskalev, E. A., Faucz, F. R., Barthelmeß, S., Wiemann, S., Bieg, M., Assié, G., Bertherat, J. Y., Schaefer, I., Otto, C., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0254 · Cited by 189 · see citing works

An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma

Buffet, A., Burnichon, N., Favier, J., & Gimenez‐Roqueplo, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101416 · Cited by 194 · see citing works

Applications of metabolomics to study cancer metabolism

Kaushik, A. K., & DeBerardinis, R. J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.009 · Cited by 179 · see citing works

Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas

Fishbein, L. M., Khare, S., Wubbenhorst, B. S., DeSloover, D., D'Andrea, K. P., Merrill, S. L., Cho, N. W., Greenberg, R. A., Else, T., Montone, K. T., et al. (2015) · Nature Communications · doi:10.1038/ncomms7140 · Cited by 186 · see citing works

Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism

Aspuria, P.-J. P., Lunt, S. Y., Väremo, L., Vergnes, L., Gozo, M. C., Beach, J. A., Salumbides, B. C., Reue, K., Wiedemeyer, W. R., Nielsen, J., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-21 · Cited by 183 · see citing works

Metabolic Signaling to the Nucleus in Cancer

Campbell, S. L., & Wellen, K. E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.015 · Cited by 182 · see citing works

Oncometabolites: Unconventional triggers of oncogenic signalling cascades

Sciacovelli, M., & Frezza, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.025 · Cited by 177 · see citing works

Germline FH Mutations Presenting With Pheochromocytoma

Clark, G. R., Sciacovelli, M., Gaude, E., Walsh, D. M., Kirby, G. A., Simpson, M. A., Trembath, R. C., Berg, J. N., Woodward, E. R., Kinning, E., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1659 · Cited by 177 · see citing works

Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer

Cassim, S., Vučetić, M., Ždralević, M., & Pouysségur, J. (2020) · Cancers · doi:10.3390/cancers12051119 · Cited by 176 · see citing works

Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma

Welander, J., Stenman, A., Juhlin, C. C., Wiseman, R. W., Bäckdahl, M., Höög, A., Larsson, C., Gimm, O., & Söderkvist, P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4375 · Cited by 172 · see citing works

Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas

Taïeb, D., Kaliski, A., Boedeker, C. C., Martucci, V. L., Fojo, T., Adler, J. R., & Pacák, K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1026 · Cited by 169 · see citing works

Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion

Kreuzaler, P. A., Panina, Y., Segal, J., & Yuneva, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.021 · Cited by 151 · see citing works

Metabolic coordination of cell fate by α-ketoglutarate-dependent dioxygenases

Baksh, S. C., & Finley, L. W. S. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.09.010 · Cited by 165 · see citing works

Malonate Promotes Adult Cardiomyocyte Proliferation and Heart Regeneration

Bae, J., Salamon, R. J., Brandt, E. B., Paltzer, W. G., Zhang, Z., Britt, E. C., Hacker, T. A., Fan, J., & Mahmoud, A. I. (2021) · Circulation · doi:10.1161/circulationaha.120.049952 · Cited by 159 · see citing works

Metabolic reprogramming, sensing, and cancer therapy

Mao, Y., Xia, Z., Xia, W., & Jiang, P. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115064 · Cited by 168 · see citing works

Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer

Guerra, F., Guaragnella, N., Arbini, A., Bucci, C., Giannattasio, S., & Moro, L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00295 · Cited by 154 · see citing works

Oncometabolites‐driven tumorigenesis: From genetics to targeted therapy

Morin, A., Letouzé, É., Gimenez‐Roqueplo, A., & Favier, J. (2014) · International Journal of Cancer · doi:10.1002/ijc.29080 · Cited by 150 · see citing works

The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells

Prochownik, E. V., & Wang, H. (2021) · Cells · doi:10.3390/cells10040762 · Cited by 145 · see citing works

Oncometabolites: tailoring our genes

Nowicki, S., & Gottlieb, E. (2015) · FEBS Journal · doi:10.1111/febs.13295 · Cited by 145 · see citing works

Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas

Toledo, R. A., Qin, Y., Cheng, Z.-M., Gao, Q., Iwata, S., Silva, G. M., Prasad, M. L., Ocal, I. T., Rao, S. N., D, N. A. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1841 · Cited by 139 · see citing works

Krebs cycle intermediates regulate DNA and histone methylation: Epigenetic impact on the aging process

Salminen, A., Kauppinen, A., Hiltunen, M. O., & Kaarniranta, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.05.004 · Cited by 142 · see citing works

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors

Morandi, A., Taddei, M. L., Chiarugi, P., & Giannoni, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00040 · Cited by 139 · see citing works

Genotype–phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis

Crona, J., Lamarca, Á., Ghosal, S., Welin, S., Skogseid, B. M., & Pacák, K. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0024 · Cited by 140 · see citing works

Characteristics And Outcomes Of Metastatic Sdhb And Sporadic Pheochromocytoma/Paraganglioma: An National Institutes Of Health Study

Turková, H., Prodanov, T., Malý, M., Martucci, V. L., Adams, K. T., Widimsky, J., Jr., Chen, C. C., Ling, A. L., Kebebew, E., Stratakis, C. A., et al. (2015) · Endocrine Practice · doi:10.4158/ep15725.or · Cited by 139 · see citing works

Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas

Buffet, A., Morin, A., Castro‐Vega, L. J., Habarou, F., Lussey‐Lepoutre, C., Letouzé, É., Lefèbvre, H., Guilhem, I., Haissaguerre, M., Raingeard, I., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2463 · Cited by 137 · see citing works

Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion

Lee, H.-J., Li, C.-F., Ruan, D., He, J.-B., Montal, E. D., Lorenz, S., Girnun, G. D., & Chan, C.-H. (2019) · Nature Communications · doi:10.1038/s41467-019-10374-y · Cited by 129 · see citing works

Cancer metabolism and tumor microenvironment: fostering each other?

Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 138 · see citing works

Mitochondria and the hallmarks of cancer

Giampazolias, E., & Tait, S. W. G. (2015) · FEBS Journal · doi:10.1111/febs.13603 · Cited by 135 · see citing works

Advances in histone demethylase KDM4 as cancer therapeutic targets

Lee, D. H., Kim, G. W., Jeon, Y. H., Yoo, J. H., Lee, S. W., & Kwon, S. H. (2020) · The FASEB Journal · doi:10.1096/fj.201902584r · Cited by 136 · see citing works

Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency

Richter, S., Peitzsch, M., Rapizzi, E., Lenders, J. W., Qin, N., de Cubas, A. A., Schiavi, F., Rao, J. U., Beuschlein, F., Quinkler, M., et al. (2014) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2014-2151 · Cited by 135 · see citing works

Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma

Job, S., Drašković, I., Burnichon, N., Buffet, A., Cros, J. F., Lépine, C., Vénisse, A., Robidel, E., Verkarre, V., Méatchi, T., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0139 · Cited by 134 · see citing works

The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity

Vatrinet, R., Leone, G., Luise, M. D., Girolimetti, G., Vidone, M., Gasparre, G., & Porcelli, A. M. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0165-0 · Cited by 130 · see citing works

Extracellular serine controls epidermal stem cell fate and tumour initiation

Baksh, S. C., Todorova, P. K., Gur-Cohen, S., Hurwitz, B., Ge, Y., Novak, J. S. S., Tierney, M. T., dela Cruz-Racelis, J., Fuchs, E., & Finley, L. W. S. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0525-9 · Cited by 128 · see citing works

Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas

Moog, S., Lussey‐Lepoutre, C., & Favier, J. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0346 · Cited by 39 · see citing works

SDHC Promoter Methylation, a Novel Pathogenic Mechanism in Parasympathetic Paragangliomas

Bernardo‐Castiñeira, C., Valdés, N., Sierra, M., Sáenz‐de‐Santa‐María, I., Bayón, G. F., Pérez, R. F., Fernández, A. F., Fraga, M. F., Astudillo, A., Menéndez, R., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01702 · Cited by 17 · see citing works

Metastatic Paragangliomas and Pheochromocytomas: An Epigenetic View

Chiara, M., Celada, L., Martínez, A. S. J., Cubiella, T., Álvarez-González, E., & Valdés, N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96126

Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells

Cervera, A. M., Bayley, J.-P., Devilee, P., & McCreath, K. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-89 · Cited by 156 · see citing works

Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas

Richter, S., Klink, B., Nacke, B., de Cubas, A. A., Mangelis, A., Rapizzi, E., Meinhardt, M., Skondra, C. D., Mannelli, M., Robledo, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3856 · Cited by 53 · see citing works